Biomarkers for hepatocellular carcinoma
J Lou, LF Zhang, S Lv, C Zhang… - Biomarkers in …, 2017 - journals.sagepub.com
Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The
HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis …
HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis …
Novel biomarkers in hepatocellular carcinoma
F De Stefano, E Chacon, L Turcios, F Marti… - Digestive and Liver …, 2018 - Elsevier
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths and
the fifth most common cancer worldwide. Most of these patients are seen with advanced …
the fifth most common cancer worldwide. Most of these patients are seen with advanced …
[HTML][HTML] Biomarkers for the early diagnosis of hepatocellular carcinoma
N Tsuchiya, Y Sawada, I Endo, K Saito… - World journal of …, 2015 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer-related deaths worldwide. Although the prognosis of patients with HCC is …
cause of cancer-related deaths worldwide. Although the prognosis of patients with HCC is …
[HTML][HTML] Biomarkers for hepatocellular cancer
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide. If diagnosed early, curative treatment options such as surgical resection, loco …
worldwide. If diagnosed early, curative treatment options such as surgical resection, loco …
[HTML][HTML] Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy
LL Han, Y Lv, H Guo, ZP Ruan… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most frequent tumors worldwide and accounts
for approximately one-third of all malignancies. In the past decade, advances have been …
for approximately one-third of all malignancies. In the past decade, advances have been …
[PDF][PDF] New and old biomarkers of hepatocellular carcinoma
G Zacharakis, A Aleid, KK Aldossari - Hepatoma Res, 2018 - f.oaes.cc
Hepatocellular carcinoma (HCC) is a significant cause of mortality in patients with chronic
liver disease around the world. Development of biomarkers for early HCC detection is a …
liver disease around the world. Development of biomarkers for early HCC detection is a …
Update on biomarkers of hepatocellular carcinoma
R Chaiteerakij, BD Addissie, LR Roberts - Clinical Gastroenterology and …, 2015 - Elsevier
New biomarkers of hepatocellular carcinoma (HCC) have been identified using advanced
genomic, proteomic, and metabolomics technologies. These are being developed not only …
genomic, proteomic, and metabolomics technologies. These are being developed not only …
[HTML][HTML] Emerging biomarkers in HCC patients: Current status
HP Marques, SG da Silva, E De Martin… - International Journal of …, 2020 - Elsevier
Hepatocellular carcinoma (HCC) is the liver's most common primary malignancy, with over
half a million new cases diagnosed each year and being the fourth leading cause of cancer …
half a million new cases diagnosed each year and being the fourth leading cause of cancer …
Diagnostic and prognostic molecular markers in hepatocellular carcinoma
B Mínguez, A Lachenmayer - Disease markers, 2011 - content.iospress.com
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide, representing
also the main cause of death among cirrhotic patients. In contrast to most other solid tumors …
also the main cause of death among cirrhotic patients. In contrast to most other solid tumors …
Biomarkers for hepatocellular carcinoma
T Behne, MS Copur - International journal of hepatology, 2012 - Wiley Online Library
The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and
carries a poor survival rate. The management of patients at risk for developing HCC remains …
carries a poor survival rate. The management of patients at risk for developing HCC remains …